Nature Communications (Nov 2023)

Acoustofluidic Interfaces for the Mechanobiological Secretome of MSCs

  • Ye He,
  • Shujie Yang,
  • Pengzhan Liu,
  • Ke Li,
  • Ke Jin,
  • Ryan Becker,
  • Jinxin Zhang,
  • Chuanchuan Lin,
  • Jianping Xia,
  • Zhehan Ma,
  • Zhiteng Ma,
  • Ruoyu Zhong,
  • Luke P. Lee,
  • Tony Jun Huang

DOI
https://doi.org/10.1038/s41467-023-43239-6
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 12

Abstract

Read online

Abstract While mesenchymal stem cells (MSCs) have gained enormous attention due to their unique properties of self-renewal, colony formation, and differentiation potential, the MSC secretome has become attractive due to its roles in immunomodulation, anti-inflammatory activity, angiogenesis, and anti-apoptosis. However, the precise stimulation and efficient production of the MSC secretome for therapeutic applications are challenging problems to solve. Here, we report on Acoustofluidic Interfaces for the Mechanobiological Secretome of MSCs: AIMS. We create an acoustofluidic mechanobiological environment to form reproducible three-dimensional MSC aggregates, which produce the MSC secretome with high efficiency. We confirm the increased MSC secretome is due to improved cell-cell interactions using AIMS: the key mediator N-cadherin was up-regulated while functional blocking of N-cadherin resulted in no enhancement of the secretome. After being primed by IFN-γ, the secretome profile of the MSC aggregates contains more anti-inflammatory cytokines and can be used to inhibit the pro-inflammatory response of M1 phenotype macrophages, suppress T cell activation, and support B cell functions. As such, the MSC secretome can be modified for personalized secretome-based therapies. AIMS acts as a powerful tool for improving the MSC secretome and precisely tuning the secretory profile to develop new treatments in translational medicine.